Michaela Purcell provides support to the RenovaCare in the areas of clinical development strategy and operations through her position as President and Founder of Shepard Clinical Development, LLC., Shepard is an independent consultancy which focusses on enabling efficient use of capital investment through value-added support of early stage companies during critical phases of clinical trial development and execution.
During her career she has led clinical research site management and mobile diagnostic businesses. She has served as Vice President of Clinical Affairs at ISTO Technologies, Inc and was responsible for strategic development, oversight and management of Clinical Operations and Medical Science Liaison functions as well as all clinical regulatory document production and interactions with regulatory bodies. Prior to this Michaela has served as Medical Communications Liaison and co-developer of Medical Liaison “onboarding” education programing at Eli Lilly.
She serves as an “Inventor Challenge Judge” for the Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship at Washington University in St Louis, a program under which industry representatives evaluate the eligibility of early preclinical projects for funding by the Center. In addition, she serves as an advisor to private investment groups to assist in evaluating clinical development risk for startup clinical biotech.
Michaela completed her undergraduate studies at Vanderbilt University and holds a master’s degree (MSN) in Teaching and Clinical Research from St Louis University.